Is gadolinium harming animals in the ocean?

With almost half a billion doses of gadolinium administered to patients across the world, traces of the imaging element have been detected in the waterways of many countries. A recent study has raised concerns of the effect on marine animals. 

Certain creatures, such as Cnidaria (which include jellyfish), small plankton and species of algae are more sensitive to gadolinium, according to a story in Hakai Magazine.

The new research found the extent to which gadolinium affects these marine animals is still unknown, but the team noted it’s also possible for the chemicals to cycle back to humans through animals or plants that absorb the contrast agent.

“We don’t put only one pollutant into [the] marine [environment]. We put a lot of different compounds. [So] this is the big issue,” said coauthor of the study Ewa Olkowska.

Read the entire story below:

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.